| Literature DB >> 24771495 |
Jianwei Hao1, Chunyi Xue, Liangliang He, Yang Wang, Yongchang Cao.
Abstract
Three strains of porcine epidemic diarrhea virus (PEDV) were isolated from dead or diseased pigs at different swine farms in Guangdong during 2011-2013, and their S genes were sequenced. In the same period, seven PEDV strains were also isolated in Guangdong by other laboratories. The spike sequences of 10 Guangdong isolates were compared with vaccine strains and reference pathogenic isolates using six bioinformatics tools. The results revealed that 10 Guangdong strains, excluding strain GDS03, had distinct characteristics in terms of primary structure, secondary structure, high-specificity N-glycosylation sites, potential phosphorylation sites, and palmitoylation sites. Phylogenetic analysis also confirmed these findings and revealed that all PEDV strains were clustered into three distinct groups. Ten Guangdong strains, not including GDS03, belong to Group 1, whereas four vaccine strains and GDS03 belong to Group 3, which is evolutionarily distant from Group 1. Alignment analysis of the neutralizing region amino acid sequences indicated that the amino acid substitutions of Y/D766S, T549S, and G594S that are present in the Guangdong strains, not including GDS03, were a sign of predominant genetic changes among the isolated strains. GDS03 is closely related to the 83P-5 vaccine strain, which suggests that it might represent re-isolation of the vaccine strain or vaccine variants. Taken together, these results indicate that there have been predominant new strains circulating in Guangdong from 2011 to 2013, and the circulating PEDV strains have a genetic composition that is distant from reference strains, especially the vaccine strains; however, the vaccinations might also provide some level of cross-protection, as there have been no changes in the neutralizing epitopes of SS2 and 2C10. This explains why there have been constant but infrequent outbreaks recently in comparison to late 2010 in which PEDV outbreaks were more frequent and severe. In addition, the USA-Colorado-2013 strain had the same amino acid substitutions in the neutralizing regions as the Guangdong strains except GDS03, which suggests that the information and strategies in this study may play role in PEDV variant research in other countries.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24771495 PMCID: PMC7088867 DOI: 10.1007/s11262-014-1055-y
Source DB: PubMed Journal: Virus Genes ISSN: 0920-8569 Impact factor: 2.332
Primers used for sequencing reactions
| Primers | Locationsa | Sequences |
|---|---|---|
| 1F | 18,874–18,896 | CGTAGCTTTTGAGTTGTATGCCA |
| 1R | 21,330–21,309 | GCAATTAGCTGTACAGGGTTCA |
| 2-1F | 21,080–21,101 | CCATTCCAGCTTATATGCGTGA |
| 2-1R | 23,487–23,465 | GTACATGTGAAGCTTCTCAGCGT |
| 2-2F | 21,188–21,205 | ATGATTGGTCCCGTGTTG |
| 2-2R | 23,386–23,365 | AGCGCTTATAGTCTTCATCAAC |
| 3F | 23,272–23,292 | GTGTACGATCCTGCAAGTGGC |
| 3R | 25,715–25,694 | TCACCTCATCAACGGGAATAGA |
aLocation corresponds to position within the CV777 (AF353511) genome
Ten Guangdong PEDV isolations and reference strains used in this study
| Virus strains | Country and year of isolation | Accession numbers | References |
|---|---|---|---|
|
| China, 2012 | AB857233 | In this study |
|
| China, 2013 | AB857234 | In this study |
|
| China, 2013 | AB857235 | In this study |
|
| China, 2011 | JQ638915 | Unpublished |
|
| China, 2011 | JX261936 | Pan et al. [ |
|
| China, 2011 | JX145339 | Unpublished |
|
| China, 2011 | JX647847 | Wei et al. [ |
|
| China, 2012 | JX112709 | Fan et al. [ |
|
| China, 2012 | JX088695 | Luo et al. [ |
|
| China, 2012 | JX489155 | Chen et al. [ |
| CV777 | Belgium, 1988 | AF353511 | Kocherhans et al. [ |
| Br1/87 | UK, 1993 | Z25483 | Duarte et al. [ |
| USA/Colorado/2013 | USA, 2013 | KF272920 | Marthaler et al. [ |
| 83P-5 | Japan | AB548618 | Sato and Takeyama [ |
| 83P-5 34th passage | Japan | AB548619 | Sato and Takeyama [ |
| 83P-5 61st passage | Japan | AB548620 | Sato and Takeyama [ |
| 83P-5 100th passage | Japan | AB548621 | Sato and Takeyama [ |
| KH | Japan | AB548622 | Sato and Takeyama [ |
| MK | Japan | AB548624 | Sato and Takeyama [ |
| NK | Japan | AB548623 | Sato and Takeyama [ |
| Attenuated DR13 | South Korea, 2001 | JQ023162 | Park et al. [ |
| Virulent DR13 | South Korea, 1999 | JQ023161 | Park et al. [ |
| Chinju99 | South Korea, 1999 | AY167285 | Yeo et al. [ |
| SM98 | South Korea | GU937797 | Unpublished |
| CNU-091222-01 | South Korea, 2009 | JN185634 | Unpublished |
| CNU-091222-02 | South Korea, 2009 | JN184635 | Unpublished |
| KNU-0801 | South Korea, 2008 | GU180142 | Lee et al. [ |
| KNU-0802 | South Korea, 2008 | GU180143 | Lee et al. [ |
| KNU-0901 | South Korea, 2009 | GU180144 | Lee et al. [ |
| KNU-0902 | South Korea, 2009 | GU180145 | Lee et al. [ |
| KNU-0903 | South Korea, 2009 | GU180146 | Lee et al. [ |
| KNU-0904 | South Korea, 2009 | GU180147 | Lee et al. [ |
| KNU-0905 | South Korea, 2009 | GU180148 | Lee et al. [ |
| CH/S | China, 1986 | JN547228 | Chen et al. [ |
| JS-2004-2 | China, 2004 | AY653204 | Unpublished |
| LJB/03 | China, 2006 | DQ985739 | Unpublished |
| LZC | China, 2006 | EF185992 | Unpublished |
| DX | China, 2007 | EU031893 | Unpublished |
| JS2008 | China, 2008 | KC210146 | Unpublished |
| BJ-2011-1 | China, 2011 | JN825712 | Yue et al. [ |
| CH-FJND-3-2011 | China, 2011 | JQ282909 | Chen et al. [ |
aThe 10 Guangdong field isolates from this study are indicated in boldface type
Fig. 1Alignment of the deduced amino acid sequences of partial S protein of Guangdong isolates with that of vaccine strains. The dots represent amino acids that are identical to those in the CV777. Boxes indicate the neutralizing epitopes (748–755, SS2; 764–771, SS6; and 1,368–1,374, 2C10). The vaccine strains are indicated with asterisk
Analysis of amino acid mutations in COEs of Guangdong sequences and reference strain CV777
| Strains | Amino acids in COE of CV777 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 511N | 517A | 521L | 523S | 527V | 549T | 567S | 577N | 594G | 605A | 606F | 611K | 612L | 621K | 633E | 635I | |
| Attenuated DR13* | – | – | H | G | I | – | – | – | – | E | – | – | F | – | Q | V |
| 83P-5 100th* | – | – | H | G | I | – | – | – | – | E | – | – | F | – | Q | V |
| SM98* | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| CH-GDHY-2011 | – | – | H | G | I | S | – | S | S | E | – | E | F | – | – | V |
| CH-GD-2011 | I | S | H | G | I | S | T | – | S | D | Y | – | F | – | – | V |
| CHGD-01 | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| LC | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| GDS01 | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| GDS02 | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| GDS03 | – | – | H | G | I | – | – | – | – | E | – | – | F | – | Q | V |
| GD-A | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| GD-B | – | S | R | G | I | S | – | – | S | D | – | – | F | T | – | V |
| GD-1 | – | – | H | G | I | S | – | – | S | E | – | – | F | – | – | V |
| USA/Colorado/2013 | – | S | – | G | I | S | – | – | S | E | – | – | F | – | – | V |
Number indicates the position for amino acids, and the dashes indicate the amino acids are identical to those of strain CV777. The vaccine strains used in other country are indicated with asterisk
Fig. 2Relationships among the Guangdong sequence set and reference strains determined using a neighbor-joining method phylogeny tree and based on complete S nucleotides. The tree reliability/robustness of the hypothesis was evaluated by bootstrap of 1,000 replicates. The Guangdong sequences are indicated with an asterisk. Groups 1–3 are shown in pink, red, and green, respectively (Color figure online)
The variation of highly specific N-glycosylation sites of 40 strains in comparison to CV777
| Strains | High-specificity N-glycosylation sites of CV777 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 127NKTL | 213NVTS | 321NDTS | 348NSSD | 511NITV | 553NVTN | 778NISI | 1246NKTL | 1258NRTG | |
| Attenuated DR13* | – | – | N | – | – | – | – | – | N |
| Virulent DR13 | – | – | – | – | – | – | – | – | – |
| 83P-5 | – | – | N | – | – | – | – | – | – |
| 83P-5 34th | – | – | N | – | – | – | – | – | – |
| 83P-5 61th | – | – | N | – | – | – | – | – | N |
| 83P-5 100th* | – | – | N | – | – | – | – | – | N |
| SM98* | – | – | – | – | – | – | – | – | N |
| Br1/87 | – | – | – | – | – | – | – | – | – |
| USA/Colorado/2013 | N | – | – | – | N | N | – | – | – |
| KH | – | – | – | – | – | N | – | – | – |
| MK | – | – | – | – | – | – | – | – | – |
| NK | – | – | – | – | N | – | – | – | – |
| Chinju99 | N | – | – | – | N | – | – | – | – |
| CNU-091222-01 | N | – | – | – | N | – | – | – | N |
| CNU-091222-02 | N | – | – | – | N | – | – | – | N |
| KNU-0801 | N | – | – | – | N | N | – | – | – |
| KNU-0802 | N | – | – | – | N | N | – | – | – |
| KNU-0901 | N | – | – | – | N | N | – | – | – |
| KNU-0902 | N | – | – | – | N | N | – | – | N |
| KNU-0903 | – | – | – | – | N | N | – | – | N |
| KNU-0904 | – | – | – | – | N | N | – | – | – |
| KNU-0905 | – | – | – | – | N | N | – | – | N |
| CH/S | – | – | – | – | – | – | – | – | – |
| JS-2004-2 | – | – | – | – | N | N | – | – | N |
| LJB/03 | – | – | – | – | N | N | – | – | – |
| LZC | – | – | – | – | – | – | – | – | – |
| DX | – | – | – | – | N | N | – | – | – |
| JS2008 | – | – | N | – | – | – | – | – | N |
| BJ-2011-1 | N | – | – | – | N | N | – | – | – |
| CH-FJND-3-2011 | N | – | – | – | N | N | – | – | – |
|
| N | – | – | – | N | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| N | – | – | – | N | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| N | – | – | N | – | N | – | – | – |
|
| N | – | – | – | – | N | – | – | – |
|
| – | – | N | – | – | – | – | – | N |
Guangdong isolates are indicated in boldface type, with the dash indicating possession of the same sites, and the “N” indicating that the strain did not contain the site, or the sites were not high-specificity sites. The vaccine strains used in other country are indicated with asterisk